BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou Y, Wang S, Ying X, Wang Y, Geng P, Deng A, Yu Z. Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer. Int J Nanomedicine 2017;12:6153-68. [PMID: 28883726 DOI: 10.2147/IJN.S141229] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Hu Z, Wang G, Zhang R, Wang L, Wang J, Hu J, Reheman A. Construction of poly(amino acid)s nano-delivery system and sustained release with redox-responsive. Colloids Surf B Biointerfaces 2023;224:113232. [PMID: 36868182 DOI: 10.1016/j.colsurfb.2023.113232] [Reference Citation Analysis]
2 Shi Y, Li C, Yang M, Pan X, Hu J. Docetaxel-loaded redox-sensitive nanoparticles self-assembling from poly(caprolactone) conjugates with disulfide-linked poly(ethylene glycol). J Biomater Sci Polym Ed 2022;33:2185-201. [PMID: 35796690 DOI: 10.1080/09205063.2022.2099664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chaudhuri A, Ramesh K, Kumar DN, Dehari D, Singh S, Kumar D, Agrawal AK. Polymeric micelles: A novel drug delivery system for the treatment of breast cancer. Journal of Drug Delivery Science and Technology 2022;77:103886. [DOI: 10.1016/j.jddst.2022.103886] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Yang F, Wei P, Yang M, Chen W, Zhao B, Li W, Wang J, Qiu L, Chen J. Redox-sensitive hyaluronic acid-ferrocene micelles delivering doxorubicin for enhanced tumor treatment by synergistic chemo/chemodynamic therepay. Journal of Drug Delivery Science and Technology 2022;77:103851. [DOI: 10.1016/j.jddst.2022.103851] [Reference Citation Analysis]
5 Sikder A, Vambhurkar G, Amulya E, Bagasariya D, Famta P, Shah S, Khatri DK, Singh SB, Sinha VR, Srivastava S. Advancements in redox-sensitive micelles as nanotheranostics: A new horizon in cancer management. J Control Release 2022;349:1009-30. [PMID: 35961470 DOI: 10.1016/j.jconrel.2022.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Renault-Mahieux M, Mignet N, Seguin J, Alhareth K, Paul M, Andrieux K. Co-encapsulation of flavonoids with anti-cancer drugs: a challenge ahead. Int J Pharm 2022;:121942. [PMID: 35728717 DOI: 10.1016/j.ijpharm.2022.121942] [Reference Citation Analysis]
7 Ghiarasim R, Tiron CE, Tiron A, Dimofte MG, Pinteala M, Rotaru A. Solid-Phase Synthesized Copolymers for the Assembly of pH-Sensitive Micelles Suitable for Drug Delivery Applications. Nanomaterials (Basel) 2022;12:1798. [PMID: 35683654 DOI: 10.3390/nano12111798] [Reference Citation Analysis]
8 Du J, Zong L, Li M, Yu K, Qiao Y, Yuan Q, Pu X. Two-Pronged Anti-Tumor Therapy by a New Polymer-Paclitaxel Conjugate Micelle with an Anti-Multidrug Resistance Effect. Int J Nanomedicine 2022;17:1323-41. [PMID: 35345783 DOI: 10.2147/IJN.S348598] [Reference Citation Analysis]
9 Gharnas‐ghamesh H, Masoumi M, Erfani‐moghadam V. Synthesis of doxorubicin‐loaded PBMA‐b‐POEGMA micelles and assessment of its anticancer activity against breast cancer cells (4T1). J of Applied Polymer Sci. [DOI: 10.1002/app.52162] [Reference Citation Analysis]
10 Gote V, Nookala AR, Bolla PK, Pal D. Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue. Int J Mol Sci 2021;22:4673. [PMID: 33925129 DOI: 10.3390/ijms22094673] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
11 Gliszczyńska A, Nowaczyk M. Lipid Formulations and Bioconjugation Strategies for Indomethacin Therapeutic Advances. Molecules 2021;26:1576. [PMID: 33809343 DOI: 10.3390/molecules26061576] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Wang S, Tan X, Zhou Q, Geng P, Wang J, Zou P, Deng A, Hu J. Co-delivery of doxorubicin and SIS3 by folate-targeted polymeric micelles for overcoming tumor multidrug resistance. Drug Deliv Transl Res 2021. [PMID: 33432521 DOI: 10.1007/s13346-020-00895-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Singh S, Singh P, Mishra N, Maurya P, Singh N, Nisha R, Saraf SA. Advanced drug delivery systems in breast cancer. Advanced Drug Delivery Systems in the Management of Cancer 2021. [DOI: 10.1016/b978-0-323-85503-7.00028-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Alven S, Aderibigbe BA. The Therapeutic Efficacy of Dendrimer and Micelle Formulations for Breast Cancer Treatment. Pharmaceutics 2020;12:E1212. [PMID: 33333778 DOI: 10.3390/pharmaceutics12121212] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
15 Chang S, Wang Y, Zhang T, Pu X, Zong L, Zhu H, Zhao L, Feng B. Redox-Responsive Disulfide Bond-Bridged mPEG-PBLA Prodrug Micelles for Enhanced Paclitaxel Biosafety and Antitumor Efficacy. Front Oncol 2019;9:823. [PMID: 31508374 DOI: 10.3389/fonc.2019.00823] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
16 Pu X, Zhao L, Li J, Song R, Wang Y, Yu K, Hou X, Qiao P, Zong L, Chang S. A polymeric micelle with an endosomal pH-sensitivity for intracellular delivery and enhanced antitumor efficacy of hydroxycamptothecin. Acta Biomater 2019;88:357-69. [PMID: 30822554 DOI: 10.1016/j.actbio.2019.02.039] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
17 Xiao K, Liu Q, Al Awwad N, Zhang H, Lai L, Luo Y, Lee JS, Li Y, Lam KS. Reversibly disulfide cross-linked micelles improve the pharmacokinetics and facilitate the targeted, on-demand delivery of doxorubicin in the treatment of B-cell lymphoma. Nanoscale 2018;10:8207-16. [PMID: 29682647 DOI: 10.1039/c8nr00680f] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
18 Pan J, Mendes LP, Yao M, Filipczak N, Garai S, Thakur GA, Sarisozen C, Torchilin VP. Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance. Eur J Pharm Biopharm 2019;136:18-28. [PMID: 30633973 DOI: 10.1016/j.ejpb.2019.01.006] [Cited by in Crossref: 59] [Cited by in F6Publishing: 43] [Article Influence: 14.8] [Reference Citation Analysis]
19 Naveen C, Shastri NR. Polysaccharide nanomicelles as drug carriers. Polysaccharide Carriers for Drug Delivery 2019. [DOI: 10.1016/b978-0-08-102553-6.00012-x] [Reference Citation Analysis]
20 Sousa D, Ferreira D, Rodrigues JL, Rodrigues LR. Nanotechnology in Targeted Drug Delivery and Therapeutics. Applications of Targeted Nano Drugs and Delivery Systems 2019. [DOI: 10.1016/b978-0-12-814029-1.00014-4] [Cited by in Crossref: 10] [Article Influence: 2.5] [Reference Citation Analysis]
21 Guo X, Cheng Y, Zhao X, Luo Y, Chen J, Yuan WE. Advances in redox-responsive drug delivery systems of tumor microenvironment. J Nanobiotechnology 2018;16:74. [PMID: 30243297 DOI: 10.1186/s12951-018-0398-2] [Cited by in Crossref: 166] [Cited by in F6Publishing: 176] [Article Influence: 33.2] [Reference Citation Analysis]
22 Fang J, Zhang S, Xue X, Zhu X, Song S, Wang B, Jiang L, Qin M, Liang H, Gao L. Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy. Int J Nanomedicine 2018;13:5113-26. [PMID: 30233175 DOI: 10.2147/IJN.S170862] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 12.0] [Reference Citation Analysis]
23 Uthaman S, Huh KM, Park IK. Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications. Biomater Res 2018;22:22. [PMID: 30155269 DOI: 10.1186/s40824-018-0132-z] [Cited by in Crossref: 83] [Cited by in F6Publishing: 89] [Article Influence: 16.6] [Reference Citation Analysis]
24 Wang S, Tan X, Li S, Zhou Y, Geng P, Hua A, Deng A, Yu Z. Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance. Oncotarget 2017;8:111281-94. [PMID: 29340053 DOI: 10.18632/oncotarget.22781] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]